Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes

Post time 2022-4-3 22:13:54

journal：JAMA

Authors：Dominik Dahl; Yukiko Onishi; Paul Norwood; Ruth Huh; Ross Bray; Hiren Patel; Angel Rodríguez

Published date：2022-2-8

DOI：10.1001/jama.2022.0078

Article link：http://dx.doi.org/10.1001/jama.2022.0078

Article Source：American Medical Association (AMA)。

Remark：

Post time 2022-4-3 22:13:55

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-4-4 12:58:35

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today